<
new post
StocksRunner logo
mail
search
 
menu
 
Regeneron Pharmaceut
$772.19
-1.89%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

REGN Stock Analysis & IQ Rating | Regeneron Pharmaceuticals

 
 

REGN

 

Regeneron Pharmaceuticals

$772.19

 
-$14.85 | -1.89%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$821.11
 
 
MKT CAP
$81.64B
 
52W Low
$476.49
 
 
VOL
$424.41K
 
P/E Ratio
N/A
 
 
AVG VOL
$844.07K
 
RSI
49.04
 
 
TREND
Sideways
 
 
 

REGN Stock IQ

 
lock  Login to see Regeneron Pharmaceuticals (REGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

REGN Target Price

 
 
 

Strengths

 
 

REGN Rewards

 Earnings are forecast to grow

REGN Rewards

 Upgraded on attractively valued

REGN Rewards

 Outperform the market

 
 

REGN Price Performance

 
 

$751.13   (+2.80%)

$780.49   (-1.06%)

$599.94   (+28.71%)

$689.5   (+11.99%)

 
 
1year
6month
3month
1month

REGN Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

REGN Earnings Sentiment Above analyst estimates
REGN Earnings Sentiment Reported a strong earnings
REGN Earnings Sentiment Earnings decline YoY

Rating

×

Rating

REGN Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

REGN Momentum Analysis Has been gaining momentum

Activity

×

Activity

Future

×

Future

REGN Future Sentiment Earnings are forecast to grow
REGN Future Sentiment Outperform the market
REGN Analysts Opinion

REGN Analysts opinion is negative and it remained unchanged from the past 3 months

REGN Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%
Consensus Rating
67%
Buy
Opinion
100%
Trend
Score
100%
Potential
Score
REGN Street Sentiment

REGN Street Sentiment is bullish and have positive views on the near-term outlook

REGN Risk Level

REGN has Low risk level

REGN Risk Level
Low
LOW
HIGH

REGN Performance Sentiment

Sentiments overview associated with events and the stock performance

74%
Positive
20 out of 27
events present
22%
Negative
6 out of 27
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$733.04
Resistance Price
$803.17
Current Price Range
$772.19
$733.04
$803.17
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
9
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Jan 09, 2026

 

Upgrade

 

Buy

 

Zacks

 

Jan 07, 2026

 

Upgrade

 

Buy

 

B of A Securities

 

Jan 07, 2026

 

Upgrade

 

Buy

 

BofA

 

Nov 24, 2025

 

Initiate

 

Buy

 

HSBC

 

Oct 30, 2025

 

Reiterate

 

Buy

 

Citigroup

 
 
 
REGN Latest Analysis +
 
 
FAQ About REGN Stock Insights
 

What is REGN current stock price?

What are REGN stock strengths?

What is REGN Risk Level?

What is REGN market cap and volume?

What is REGN current Stock IQ?

Should I buy REGN stock right now?

Is REGN a Strong Buy right now?

What does a 'Strong Buy' rating mean for REGN?

What does a 'Strong Sell' rating mean for REGN?

What factors influence REGN's Stock IQ?

 
 
StocksRunner

Explore our REGN Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored REGN Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our REGN Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

REGN

 

Regeneron Pharmaceuticals

 
Set Alerts
 
 

Current Price

 

$772.19

 
-$14.85 | -1.89%
 
 
52W High
$821.11
 
 
MKT CAP
$81.64B
 
52W Low
$476.49
 
 
VOL
$424.41K
 
P/E Ratio
N/A
 
 
AVG VOL
$844.07K
 
RSI
49.04
 
 
TREND
Sideways
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

REGN Price Performance

 
 

$751.13   (+2.80%)

$780.49   (-1.06%)

$599.94   (+28.71%)

$689.5   (+11.99%)

 
 
1year
6month
3month
1month
 

REGN Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

REGN Earnings Sentiment Above analyst estimates
REGN Earnings Sentiment Reported a strong earnings
REGN Earnings Sentiment Earnings decline YoY

Rating

×

Rating

REGN Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

REGN Momentum Sentiment Has been gaining momentum

Activity

×

Activity

Future

×

Future

REGN Future Sentiment Earnings are forecast to grow
REGN Future Sentiment Outperform the market
REGN Analysts Opinion

REGN Analysts opinion is negative and it remained unchanged from the past 3 months

REGN Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%
Consensus Rating
67%
Buy
Opinion
100%
Trend
Score
100%
Potential
Score
REGN Street Sentiment

REGN Street Sentiment is bullish and have positive views on the near-term outlook

REGN Risk Level

REGN has Low risk level

REGN Risk Level
Low
LOW
HIGH
REGN Performance Sentiment
Sentiments overview associated with events and the stock performance.
74%
Positive
20 out of 27
events present
22%
Negative
6 out of 27
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$733.04
Resistance Price
$803.17
Current Price Range
$772.19
$733.04
$803.17
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
9
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Jan 09, 2026
Upgrade
Buy
Zacks
Jan 07, 2026
Upgrade
Buy
B of A Securities
Jan 07, 2026
Upgrade
Buy
BofA
Nov 24, 2025
Initiate
Buy
HSBC
Oct 30, 2025
Reiterate
Buy
Citigroup
Oct 30, 2025
Reiterate
Buy
Guggenheim
Oct 30, 2025
Reiterate
Overweight
Cantor Fitzgerald
 
 
 
 

REGN Stock IQ

 
 
 
lock  Login to unlock Regeneron Pharmaceuticals (REGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

REGN Rewards

 Earnings are forecast to grow

REGN Rewards

 Upgraded on attractively valued

REGN Rewards

 Outperform the market

 
 
 

REGN Latest Analysis

 
 
 

FDA Accepts Regeneron (REGN) BLA for Garetosmab Under Priority Review. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the best value stocks to buy now. On February 19 Regeneron Pharmaceuticals announced that the FDA accepted its BLA for garetosmab for Priority Review. This investigational monoclonal antibody is designed to treat adults with fibrodysplasia ossificans progressiva/FOP which is an ultra-rare and devastating genetic disorder where muscles and [….]

 

Tue Feb 24, 2026

$772.19 | -1.89%
 
Activity

Regeneron granted FDA priority review for rare bone disorder therapy.

 

Thu Feb 19, 2026

$782.38 | -1.23%
 
Activity

Regeneron Pharma Says FDA Accepts Garetosmab BLA For Priority Review For Adults With FOP . (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced Thursday that the United States Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for garetosmab for the treatment of adults with fibrodysplasia ossificans progressiva (F

 

Thu Feb 19, 2026

$782.38 | -1.23%
 
Activity

Ex-Dividend Reminder: ONE Gas AstraZeneca and Regeneron Pharmaceuticals. Looking at the universe of stocks we cover at Dividend Channel on 2/20/26 ONE Gas Inc. (Symbol: OGS) AstraZeneca plc (Symbol: AZN) and Regeneron Pharmaceuticals Inc. (Symbol: REGN) will all trade ex-dividend for their respective upcoming dividends. ONE Gas Inc. will pay i

 

Wed Feb 18, 2026

$792.16 | -0.17%
 
Activity

Where is Regeneron Pharmaceuticals (REGN) Headed According to Analysts?. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the best medical research stocks to buy according to hedge funds. RBC Capital reiterated a Hold rating on Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) on February 10 setting a price target of $745.00. In another development Guggenheim lifted the price target on Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) to $975 from $865 [….]

 

Fri Feb 13, 2026

$803.17 | +2.49%
 
Potential

Will Eylea Sales Decline Weigh on REGNs Top Line in 2026?. Regeneron foresees further Eylea decline in 2026 as biosimilars loom but Eylea HD Dupixent and Libtayo aim to steady revenues.

 

Thu Feb 12, 2026

$783.65 | +0.60%
 
Activity

The Zacks Analyst Blog Highlights NVIDIA Amazon.com Regeneron National Presto and AXIL. NVDA AMZN and REGN headline Zacks top stock reports spotlighting AI growth cloud momentum and oncology pipeline strength.

 

Wed Feb 11, 2026

$778.97 | +3.19%
 
Potential
 
 
 
 
 
StocksRunner

Discover REGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of REGN. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our REGN Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

REGN Stock trends

REGN Stock performance

REGN Stock analysis

REGN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

REGN Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing REGN

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing REGN

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.